Earnings Call · Q4 FY2021·2022-03-17

Q4 21EPS +6.67%·Rev n/aQ3 21EPS +12.82%·Rev n/aQ2 21EPS -6.52%·Rev n/aQ1 21EPS +17.31%·Rev n/a⚠ consensus missing

Trevi Therapeutics, Inc. TRVI

Jennifer Good — Chief Executive Officer

Lisa Delfini — Chief Financial Officer

+9.8%1d on move date+8.7% vs SPY3d+45.8%5d+28.8%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TRVI calls or request research access.

More TRVI calls Browse calls Request research access